ID
16305
Description
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00433407
Link
https://clinicaltrials.gov/show/NCT00433407
Keywords
Versions (1)
- 7/10/16 7/10/16 -
Uploaded on
July 10, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00433407
Eligibility Breast Cancer NCT00433407
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00433407
- StudyEvent: Eligibility
C1368683 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,2])
C0162789 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2])